SINTX Technologies (NASDAQ:SINT) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call.
This transcript is brought to you by Benzinga APIs. For real-time access toread more...
SINTX Technologies (NASDAQ:SINT) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call.
This transcript is brought to you by Benzinga APIs. For real-time access toread more...
SINTX TECHNOLOGIES (SINT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
SINTX TECHNOLOGIES (SINT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Globus Medical (GMED) delivered earnings and revenue surprises of +19.64% and +0.35%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
LivaNova (LIVN) delivered earnings and revenue surprises of +16.67% and +2.90%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -31.03% and -16.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
AxoGen (AXGN) delivered earnings and revenue surprises of +33.33% and +4.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
PAVmed (PAVM) delivered earnings and revenue surprises of -69.57% and -78.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Sangamo (SGMO) delivered earnings and revenue surprises of -100.00% and -84.82%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Rapid Micro Biosystems (RPID) delivered earnings and revenue surprises of -24.00% and +6.69%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?